Hrt Financial LP Scholar Rock Holding Corp Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$7.36 - $12.72 $469,391 - $811,230	63,776 New	63,776 $510,000
Q2 2022 Aug 12, 2022	BUY	$4.66 - $13.96 $389,221 - $1.17 Million	83,524 Added 269.78%	114,484 $628,000
Q1 2022 May 16, 2022	BUY	$11.89 - $24.68 $368,114 - $764,092	30,960 New	30,960 $399,000
Q4 2021 Feb 14, 2022	SELL	$24.14 - $35.18 $483,838 - $705,112	-20,043 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$27.38 - $42.21 $548,777 - $846,015	20,043 New	20,043 $661,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.